Literature DB >> 32634334

Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?

Lawrence H Einhorn1, Nabil Adra1, Nasser Hanna1, Craig Nichols1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32634334     DOI： 10.1200/JCO.20.00702

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Reply to L.H. Einhorn et al.

Authors:  Deaglan McHugh; George J Bosl; Samuel A Funt; Darren R Feldman
Journal:  J Clin Oncol       Date:  2020-07-07       Impact factor: 44.544

2.  Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma.

Authors:  Xiaoxi Shi; Yuanlin Liu; Shuai Cheng; Haidi Hu; Jian Zhang; Minjie Wei; Lin Zhao; Shijie Xin
Journal:  Front Oncol       Date:  2021-07-21       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.